​Major Projects

Our research team has been conducting comprehensive studies investigating the epidemiology, genetics, pathogenesis, and treatment of IBD. We are the pioneer of the first large scale epidemiologic study of IBD across 15 countries in Asia-Pacific and an Asian Microbiota Consortium. We developed the Hong Kong IBD Registry to determine disease burden locally and set up studies of natural history and environmental risk factors of IBD to identify potential aetiological factors and preventive strategies.

ENIGMA

The ENIGMA Consortium comprised of leading clinicians, microbiologists and scientists aims to make discoveries about key microbial organisms and related environmental factors that cause or contribute to the development of Crohn’s disease.

ASSURANCE

The ASSURANCE programme aims to define the colorectal cancer (CRC) risk in geographically diverse IBD patient populations, to monitor screening outcomes according to the physician’s approach, evaluate adherence to guidelines and assess any cost benefits of surveillance. These data will help shape future CRC surveillance strategies in this at-risk population.

Copyright © 2017. All Rights Reserved. Institute of Digestive Disease, The Chinese University of Hong Kong